BRAF, which regulates the Ras–Raf–MEK–ERK pathway and is associated with poor prognosis in CRC, was selected as a key driver, even though its mutation rate was slightly lower than that of other genes. This evidence concerns the gene MAP2K7 and colorectal carcinoma.